191 related articles for article (PubMed ID: 37431844)
1. Investigating the impact of metformin on severity of COVID-19 in patients with Type 2 diabetes mellitus: Focusing on laboratory findings.
Taheri R; Shahrokhi SZ; Amjadi Z; Kazerouni F
Endocrinol Diabetes Metab; 2023 Sep; 6(5):e441. PubMed ID: 37431844
[TBL] [Abstract][Full Text] [Related]
2. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
[TBL] [Abstract][Full Text] [Related]
3. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA.
Ghany R; Palacio A; Dawkins E; Chen G; McCarter D; Forbes E; Chung B; Tamariz L
Diabetes Metab Syndr; 2021; 15(2):513-518. PubMed ID: 33662839
[TBL] [Abstract][Full Text] [Related]
4. Effects of Metformin, Insulin on Hematological Parameters of COVID-19 Patients with Type 2 Diabetes.
Petakh P; Griga V; Mohammed IB; Loshak K; Poliak I; Kamyshnyiy A
Med Arch; 2022 Oct; 76(5):329-332. PubMed ID: 36545453
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
[TBL] [Abstract][Full Text] [Related]
6. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
Luo P; Qiu L; Liu Y; Liu XL; Zheng JL; Xue HY; Liu WH; Liu D; Li J
Am J Trop Med Hyg; 2020 Jul; 103(1):69-72. PubMed ID: 32446312
[TBL] [Abstract][Full Text] [Related]
7. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
[TBL] [Abstract][Full Text] [Related]
8. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
[TBL] [Abstract][Full Text] [Related]
9. Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
Gao Y; Liu T; Zhong W; Liu R; Zhou H; Huang W; Zhang W
Clin Transl Sci; 2020 Nov; 13(6):1055-1059. PubMed ID: 32955785
[TBL] [Abstract][Full Text] [Related]
10. Metformin and COVID-19: From cellular mechanisms to reduced mortality.
Scheen AJ
Diabetes Metab; 2020 Nov; 46(6):423-426. PubMed ID: 32750451
[TBL] [Abstract][Full Text] [Related]
11. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
Jornayvaz FR; Assouline B; Pugin J; Gariani K
BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
[TBL] [Abstract][Full Text] [Related]
12. Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort.
Wong CKH; Lui DTW; Lui AYC; Low MCH; Kwok ACY; Lau KTK; Au ICH; Xiong X; Chung MSH; Lau EHY; Cowling BJ
Front Endocrinol (Lausanne); 2022; 13():810914. PubMed ID: 35321338
[TBL] [Abstract][Full Text] [Related]
13. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
Scheen AJ; Paquot N
Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
[TBL] [Abstract][Full Text] [Related]
14. Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
Do JY; Kim SW; Park JW; Cho KH; Kang SH
Diabetes Metab; 2021 Jul; 47(4):101208. PubMed ID: 33160030
[TBL] [Abstract][Full Text] [Related]
15. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
[TBL] [Abstract][Full Text] [Related]
16. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review.
Plowman TJ; Christensen H; Aiges M; Fernandez E; Shah MH; Ramana KV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791227
[TBL] [Abstract][Full Text] [Related]
17. Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.
Wiernsperger N; Al-Salameh A; Cariou B; Lalau JD
Diabetes Metab; 2022 Jul; 48(4):101359. PubMed ID: 35662580
[TBL] [Abstract][Full Text] [Related]
18. Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications.
Olawore O; Turner LE; Evans MD; Johnson SG; Huling JD; Bramante CT; Buse JB; Stürmer T;
Clin Epidemiol; 2024; 16():379-393. PubMed ID: 38836048
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail.
Pal R; Bhasin MK; Bhadada SK
Infect Disord Drug Targets; 2021; 21(5):e270421186842. PubMed ID: 33050869
[TBL] [Abstract][Full Text] [Related]
20. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
